Lobbying Information
Subject Matters
- Health
- Industry
- Intellectual Property
- Research and Development
- Science and Technology
Subject Matter Details
Policies or Program
- Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
- Health Canada Regulatory Review of Drugs and Devices, including potential regulatory reforms with respect to drugs for rare diseases
- Health system policies with respect to pharmaceuticals, including drugs for rare diseases
- Innovation agenda led by Innovation, Science and Economic Development Canada, particularly with respect to the life sciences industry
- Patented Medicine Prices Review Board (PMPRB) guidelines with respect to non-excessive pricing of patented medicines
Policies or Program, Regulation
- Health Canada's Special Access Program (SAP) and associated regulations and guidelines
Regulation
- Patented Medicine Prices Review Board (PMPRB) regulations with respect to non-excessive pricing of patented medicines
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Health Canada (HC)
-
House of Commons
-
Innovation, Science and Economic Development Canada (ISED)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Senate of Canada
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
9131 Keele Street, Unit 4A
Vaughn, ON L4K 0G7
Canada
Telephone number:
224-383-3000
Client representative
Matt McCarthy, Head of Sales and Marketing
Parent Company Information
- Horizon Pharma plc
-
Connaught House, 1st Floor
1 Burlington Road
Dublin D04C5Y6
Ireland
Coalition Members Information
Horizon Therapeutics Canada is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Horizon Therapeutics Canada are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Horizon Therapeutics Canada does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
Stephen Sampson
|
Public offices held
Business address:
50 O'Connor St., Suite 901
Ottawa, ON K1P 6L2
Canada
Telephone number:
613-782-2336
Consultant Firm and Address
Firm:
Global Public Affairs
Address:
50 O'Connor St., Suite 901
Ottawa, ON K1P 6L2
Canada
Telephone number:
613-782-2336